All Clinical Trials
Filter by Category
- All Clinical Trials
- Clinical Studies
- Treatment-Naive
- Treatment-Experienced
- Switch/Simplification
- Dual Therapy
- Monotherapy
- PREP
- PEP
- Acute HIV
- Resistance/Virological Failure
- Pharmacology
- General Pharmacology
- Adverse Effects
- Drug Interactions
- Pregnancy/Women
- Pediatrics
- Review
Official Title A Multi-arm Phase 3 Randomized Placebo Controlled Double Blind Clinical Trial to Investigate the Efficacy and Safety of Fostemsavir (BMS-663068) in Heavily Treatment Experienced Subjects Infected With Multi-drug Resistant HIV-1
Purpose / DescriptionPhase III
Phase Phase III
ClinicalTrials.gov NCT02362503
Treatments
Fostemsavir![Fostemsavir Rukobia](https://cdn.hiv.uw.edu/css/images/drugs/140.png)
![Fostemsavir Rukobia](https://cdn.hiv.uw.edu/css/images/drugs/140.png)
Fostemsavir
Tradename:RukobiaOther Names:FTRClass:Entry InhibitorsCategories Resistance/Virological FailureTreatment-Experienced
Funding
IndustryBristol-Myers Squibb
References
- Kozal M, Aberg J, Pialoux G, et al. Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection. N Engl J Med. 2020;382:1232-43.